Evidence map›Paper›PMID 24875183›Full record

ArticlePloS one2014

SIRT1 mediates FOXA2 breakdown by deacetylation in a nutrient-dependent manner.

Rogier van Gent, Claudio Di Sanza, Niels J F van den Broek, Veerle Fleskens, Aukje Veenstra, Gerdine J Stout, Arjan B Brenkman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Sirtuins in epigenetic regulation.Chemical reviews · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rogier van GentCenter for Molecular Medicine, Department of Molecular Cancer Research, Section Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands, and Netherlands Metabolomics Centre, Leiden, The Netherlands; Erasmus Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
Claudio Di SanzaCenter for Molecular Medicine, Department of Molecular Cancer Research, Section Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands, and Netherlands Metabolomics Centre, Leiden, The Netherlands.
Niels J F van den BroekCenter for Molecular Medicine, Department of Molecular Cancer Research, Section Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands, and Netherlands Metabolomics Centre, Leiden, The Netherlands.
Veerle FleskensUniversity Medical Center Utrecht, Department of Cell Biology, Utrecht, The Netherlands.
Aukje VeenstraCenter for Molecular Medicine, Department of Molecular Cancer Research, Section Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands, and Netherlands Metabolomics Centre, Leiden, The Netherlands.
Gerdine J StoutCenter for Molecular Medicine, Department of Molecular Cancer Research, Section Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands, and Netherlands Metabolomics Centre, Leiden, The Netherlands.
Arjan B BrenkmanCenter for Molecular Medicine, Department of Molecular Cancer Research, Section Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands, and Netherlands Metabolomics Centre, Leiden, The Netherlands.
University Medical Center Utrecht · NLNetherlands Metabolomics Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Forkhead transcription factor FOXA2 plays a fundamental role in controlling metabolic homeostasis in the liver during fasting. The precise molecular regulation of FOXA2 in response to nutrients is not fully understood. Here, we studied whether FOXA2 could be controlled at a post-translational level by acetylation. By means of LC-MS/MS analyses, we identified five acetylated residues in FOXA2. Sirtuin family member SIRT1 was found to interact with and deacetylate FOXA2, the latter process being dependent on the NAD+-binding catalytic site of SIRT1. Deacetylation by SIRT1 reduced protein stability of FOXA2 by targeting it towards proteasomal degradation, and inhibited transcription from the FOXA2-driven G6pase and CPT1a promoters. While mutation of the five identified acetylated residues weakly affected protein acetylation and stability, mutation of at least seven additional lysine residues was required to abolish acetylation and reduce protein levels of FOXA2. The importance of acetylation of FOXA2 became apparent upon changes in nutrient levels. The interaction of FOXA2 and SIRT1 was strongly reduced upon nutrient withdrawal in cell culture, while enhanced Foxa2 acetylation levels were observed in murine liver in vivo after starvation for 36 hours. Collectively, this study demonstrates that SIRT1 controls the acetylation level of FOXA2 in a nutrient-dependent manner and in times of nutrient shortage the interaction between SIRT1 and FOXA2 is reduced. As a result, FOXA2 is protected from degradation by enhanced acetylation, hence enabling the FOXA2 transcriptional program to be executed to maintain metabolic homeostasis.

Indexed as

Animal FeedAcetylationActive Transport, Cell NucleusAnimalsCatalysisCell LineGene Expression RegulationHepatocyte Nuclear Factor 3-betaHumansLiverMiceProtein BindingProtein Processing, Post-TranslationalProtein TransportSirtuin 1StarvationFoxa2 protein, mouseHepatocyte Nuclear Factor 3-betaSirtuin 1

Identifiers

PMID24875183
PMCPMC4038515
OpenAlexW2032164605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.